Literature DB >> 2783403

The role of T cell phenotypes in decreased lymphoproliferation of the elderly.

D Matour1, M Melnicoff, D Kaye, D M Murasko.   

Abstract

A possible mechanism of the decreased mitogen-induced lymphoproliferation of the elderly is a shift in the relative numbers of T lymphocyte subpopulations. Results from studies examining such changes have been conflicting. In an effort to resolve this conflict, alterations in T cell subsets in the peripheral blood of a large number of relatively healthy, elderly subjects (149; mean age 84.6) were evaluated. Although there were several differences in percentages of subpopulations between elderly and young subjects, no significant differences in the absolute numbers of lymphocytes, monocytes, or T cell subsets between the groups were observed. In addition, there was no correlation between mitogen-induced lymphoproliferation and T cell subsets. Since the decreased mitogen response could reflect a difference in the ability of one T cell subset to proliferate, the phenotype of the T cells after stimulation with PHA was determined. Although the elderly demonstrated a decreased number of all T cell subsets after PHA stimulation compared to young subjects, the most pronounced decrease was in CD8+ cells. Further, young individuals demonstrated a significant increase in the percentage of CD8+ cells (p less than 0.001) after 72 hr of culture with PHA; elderly subjects showed no change in the percentage of T cell subsets. Although both groups had an increase in interleukin 2 receptor (IL2R), transferrin receptor (TfR), and MHC class II Ag (HLA-DR) positive cells after PHA stimulation, the mean percentage of TfR+ cells was significantly greater in the young than in the elderly (p less than 0.05). This decreased expression of TfR+ cells in the elderly was reflected by a decreased percentage of CD8+ cells expressing TfR. In addition, the percentages of CD8+ cells, CD8+ cells expressing TfR, and CD8+ cells expressing IL2R after activation correlated with PHA-induced proliferation. These results suggest that the impaired lymphoproliferative ability of elderly cells is not related to the proportions of T cell subsets present in peripheral blood. Rather, there appears to be some defect in the ability of all T cells, but especially of the T suppressor/cytotoxic cells, of the elderly to respond to PHA manifested by a decreased expression of transferrin receptors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2783403     DOI: 10.1016/0090-1229(89)90224-9

Source DB:  PubMed          Journal:  Clin Immunol Immunopathol        ISSN: 0090-1229


  5 in total

1.  Numerical and functional characteristics of lymphocyte subsets in centenarians.

Authors:  C Miyaji; H Watanabe; M Minagawa; H Toma; T Kawamura; Y Nohara; H Nozaki; Y Sato; T Abo
Journal:  J Clin Immunol       Date:  1997-09       Impact factor: 8.317

2.  Effect of age on cytokine production in humans.

Authors:  E D Bernstein; D M Murasko
Journal:  Age (Omaha)       Date:  1998-10

3.  Phenotypic and functional characterization of lymphocytes derived from normal and HIV-1-infected human lymph nodes.

Authors:  N Tedla; J Dwyer; P Truskett; D Taub; D Wakefield; A Lloyd
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

4.  CD3zeta expression and T cell proliferation are inhibited by TGF-beta1 and IL-10 in cervical cancer patients.

Authors:  Cinthya E Díaz-Benítez; Karla R Navarro-Fuentes; Jacqueline A Flores-Sosa; Janet Juárez-Díaz; Felipe J Uribe-Salas; Edgar Román-Basaure; Ludwig E González-Mena; Patricia Alonso de Ruíz; Guillermina López-Estrada; Alfredo Lagunas-Martínez; Victor H Bermúdez-Morales; Juan M Alcocer-González; Jesús Martínez-Barnetche; Rogelio Hernández-Pando; Yvonne Rosenstein; José Moreno; Vicente Madrid-Marina
Journal:  J Clin Immunol       Date:  2009-03-04       Impact factor: 8.317

Review 5.  Cytokine production pathway in the elderly.

Authors:  C Caruso; G Candore; D Cigna; G DiLorenzo; G Sireci; F Dieli; A Salerno
Journal:  Immunol Res       Date:  1996       Impact factor: 2.829

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.